510(k) K901475
K901475 is an FDA 510(k) premarket notification submitted by Baxter Healthcare Corp for the device "CLINICAL ASSAYS(TM) GAMMACOAT(TM) M [125I] T4". The FDA issued a decision of Substantially Equivalent on June 20, 1990. The device falls under product code CDX (Radioimmunoassay, Total Thyroxine), a Class II device regulated under 21 CFR 862.1700. Baxter Healthcare Corp has at least 10 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- June 20, 1990
- Date Received
- March 27, 1990
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Radioimmunoassay, Total Thyroxine
- Device Class
- Class II
- Regulation Number
- 862.1700
- Review Panel
- CH
- Submission Type